Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

1,322 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   (11c)pe2i   -   -   -   -   [1]
6 
 2   (2-chloro-5-[11c]methoxy-n-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide)   -   -   -   -   [1]
6 
 3   (3beta, 5beta, 25r)-spirostan-3-ol   -   -   -   -   [1]
6 
 4   (3ß, 5ß, 25r)-spirostan-3-ol   -   -   -   -   [1]
6 
 5   (6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol   -   -   -   -   [1]
6 
 6   (r)-troloxamide quinone   -   -   -   -   [1]
6 
 7   (s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol   -   -   -   -   [1]
6 
 8   (s)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate   -   -   -   -   [1]
6 
 9   0 mg tropicamide   Tropicamide   D00397   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 10   0.3 mg tropicamide   Tropicamide   D00397   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 11   0.9% sodium chloride   Sodium chloride   D02056   -   -   [3]
6,
14,
51 
 12   0.9% sodium chloride (normal saline)   Sodium chloride   D02056   -   -   [1]
6 
 13   009-0   -   -   -   -   [1]
6 
 14   009-1   -   -   -   -   [1]
6 
 15   009-2   -   -   -   -   [1]
6 
 16   009-3   -   -   -   -   [1]
6 
 17   009-4   -   -   -   -   [1]
6 
 18   009-5   -   -   -   -   [1]
6 
 19   009-a0   -   -   -   -   [1]
6 
 20   009-a1   -   -   -   -   [1]
6 
 21   009-a2   -   -   -   -   [1]
6 
 22   009-a3   -   -   -   -   [1]
6 
 23   1 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 24   1 mg qd to 7 mg qd pf-06649751 (if de-escalated in parent study)   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 25   1 mg tropicamide   Tropicamide   D00397   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 26   1. tesofensine (ns 2330)   Tesofensine   -   -   -   [1]
6 
 27   1.0 mg rasagiline mesylate   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 28   11c-pbr28   -   -   -   -   [1]
6 
 29   11c-raclopride   Raclopride   -   -   -   [1]
6 
 30   15 mg qd de-escalated to 7 mg qd pf-06649751 in parent study remain at 7 mg qd   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 31   15 mg qd pf-06649751   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 32   15o h2o   -   -   -   -   [1]
6 
 33   18-fdtbz   -   -   -   -   [1]
6 
 34   18f florbetaben   -   -   -   -   [1]
6 
 35   18f- dtbz   -   -   -   -   [1]
6 
 36   18f-av-133   Florbenazine f-18   -   -   -   [1]
6 
 37   18f-av-45   -   -   -   -   [2]
6,
127 
 38   18f-dopa   -   -   -   -   [2]
6,
75 
 39   18f-dopa pet   -   -   -   -   [1]
6 
 40   18f-dtbz   -   -   -   -   [1]
6 
 41   18f-dtbz av-133   -   -   -   -   [1]
6 
 42   18f-fdg   Fludeoxyglucose f-18   -   -   -   [7]
6,
13,
46,
53,
84,
127,
300 
 43   1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-   -   -   -   -   [1]
6 
 44   1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea   -   -   -   -   [1]
6 
 45   1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]-   -   -   -   -   [1]
6 
 46   1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea   -   -   -   -   [1]
6 
 47   2 mg perampanel   Perampanel   D08964   [4] GRIA1, GRIA2, GRIA3, GRIA4   [13] Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   [1]
6 
 48   200 mg bia 6-512   -   -   -   -   [1]
6 
 49   207-3120   -   -   -   -   [1]
6 
 50   240mg amantadine hcl er tablets   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 51   25330   -   -   -   -   [1]
6 
 52   3 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 53   3 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 54   3 mg tropicamide   Tropicamide   D00397   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 55   3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate   -   -   -   -   [1]
6 
 56   320mg amantadine hcl er tablets   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 57   4 mg perampanel   Perampanel   D08964   [4] GRIA1, GRIA2, GRIA3, GRIA4   [13] Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   [1]
6 
 58   6abeta - apomorphine-10,11-diol hydrochloride hemihydrate   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 59   6aß - apomorphine-10,11-diol hydrochloride hemihydrate   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 60   7 mg qd to 15 mg qd pf-06649751   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 61   7 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 62   7-beta-hydroxyepiandrosterone   -   -   -   -   [1]
6 
 63   [11c]pbr28   -   -   -   -   [1]
6 
 64   [11c]pxt012253   -   -   -   -   [1]
6 
 65   [11c]smw139   -   -   -   -   [1]
6 
 66   [123i] 5-ia   -   -   -   -   [1]
6 
 67   [123i] ibvm and spect imaging   -   -   -   -   [1]
6 
 68   [123i] mzint injection and serial dynamic spect imaging   -   -   -   -   [1]
6 
 69   [123i]-ibvm   -   -   -   -   [1]
6 
 70   [123i]b-cit   -   -   -   -   [1]
6 
 71   [123i]b-cit spect imaging   -   -   -   -   [1]
6 
 72   [123i]beta cit   -   -   -   -   [1]
6 
 73   [123i]beta cit and spect imaging   -   -   -   -   [1]
6 
 74   [123i]beta-cit   -   -   -   -   [1]
6 
 75   [123i]beta-cit and spect imaging   -   -   -   -   [1]
6 
 76   [123i]clinde   -   -   -   -   [2]
6,
13 
 77   [123i]mni-420   -   -   -   -   [2]
6,
8 
 78   [123i]ß cit   -   -   -   -   [1]
6 
 79   [123i]ß cit and spect imaging   -   -   -   -   [1]
6 
 80   [123i]ß-cit   -   -   -   -   [1]
6 
 81   [123i]ß-cit and spect imaging   -   -   -   -   [1]
6 
 82   [14c]-bia 9-1067   -   -   -   -   [1]
6 
 83   [15o]h2o   -   -   -   -   [1]
6 
 84   [18f] cfpypb   -   -   -   -   [1]
6 
 85   [18f] lbt-999 pet   -   -   -   -   [1]
6 
 86   [18f] pbr06   -   -   -   -   [2]
6,
13 
 87   [18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane   -   -   -   -   [1]
6 
 88   [18f]-feppa   -   -   -   -   [2]
6,
13 
 89   [18f]dpa-714 pet scan   -   -   -   -   [1]
6 
 90   [18f]fdopa pet/ct   -   -   -   -   [1]
6 
 91   [18f]fe-pe2i   -   -   -   -   [1]
6 
 92   [18f]fpeb   -   -   -   -   [3]
6,
8,
206 
 93   [18f]mk-9470   -   -   -   -   [1]
6 
 94   [18f]mni-1126   -   -   -   -   [1]
6 
 95   [18f]mppf   -   -   -   -   [1]
6 
 96   [18f]nos   -   -   -   -   [1]
6 
 97   [18f]p17-059   -   -   -   -   [1]
6 
 98   [18f]t807 ([18f]mni-777)   -   -   -   -   [2]
5,
6 
 99   Ab1010   Masitinib   D10229   [1] KIT   [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   [6]
2,
5,
6,
13,
46,
96 
 100   Abbv-0805   -   -   -   -   [1]
6 
 101   Abbv-951   -   -   -   -   [1]
6 
 102   Abt-slv187   -   -   -   -   [1]
6 
 103   Acamprosate   Acamprosate   D02780, D07058   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [2]
6,
206 
 104   Accordion pill carbidopa/levodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 105   Accordion pill™ carbidopa/levodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 106   Accordion pill™ carbidopa/levodopa 50/400 mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 107   Accordion pill™ carbidopa/levodopa 50/500 mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 108   Acetate   Acetate   -   -   -   [40]
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 109   Acetylcysteine   Acetylcysteine   D00221   -   -   [14]
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 110   Acp-103   -   -   -   -   [1]
6 
 111   Acr325   Acr325   -   -   -   [1]
6 
 112   Active comparator   -   -   -   -   [2]
6,
46 
 113   Active drug (biib014) at 10, 30, 100, or 300 mg once daily.   Dihydrotachysterol   D00299   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [1]
6 
 114   Active drug: pimavanserin 17mg (2 strength tablets)   Pimavanserin   -   -   -   [1]
6 
 115   Active investigational treatment ent-01   -   -   -   -   [1]
6 
 116   Ad-810n (zonisamide)   Zonisamide   D00538   [8] CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [11] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus   [1]
6 
 117   Adjuvant without active component   -   -   -   -   [2]
6,
17 
 118   Administration of stable isotope-labelled leucine-   L-leucine   D00030   -   -   [1]
6 
 119   Ads-5102   -   -   -   -   [2]
6,
13 
 120   Ads-5102 (extended release amantadine hcl)   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 121   Adx48621   -   -   -   -   [1]
6 
 122   Affitope® pd01a   -   -   -   -   [1]
6 
 123   Affitope® pd01a + adjuvant   -   -   -   -   [2]
6,
17 
 124   Afq056   -   -   -   -   [3]
6,
8,
206 
 125   Afq056 with l-dopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 126   Agomelatine   Agomelatine   D02578   [3] HTR2C, MTNR1A, MTNR1B   [6] Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   [1]
6 
 127   Agomelatine or piacebo   Agomelatine   D02578   [3] HTR2C, MTNR1A, MTNR1B   [6] Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   [1]
6 
 128   Allogeneic bone marrow-derived mscs   -   -   -   -   [1]
6 
 129   Allopurinol   Allopurinol   D00224   [1] XDH   [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   [6]
6,
46,
57,
66,
96,
97 
 130   Altropane   Altropane   -   -   -   [1]
6 
 131   Altropane®   Altropane   -   -   -   [1]
6 
 132   Amantadine   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [4]
6,
8,
13,
127 
 133   Amantadine 300 mg   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 134   Amantadine hcl er   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 135   Amantadine hcl extended release   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 136   Amantadine hydrochloride   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 137   Amantadine sulfate   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 138   Ambrosan 60mg tablets   -   -   -   -   [1]
6 
 139   Ambroxol   Ambroxol   D07442   -   -   [2]
6,
19 
 140   Ambroxol hydrochloride   Ambroxol   D07442   -   -   [1]
6 
 141   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   [6]
6,
46,
63,
96,
97,
222 
 142   Ampyra first,   -   -   -   -   [1]
6 
 143   Anavex2-73   -   -   -   -   [2]
6,
156 
 144   Anti-parkinson medication   -   -   -   -   [4]
5,
6,
7,
17 
 145   Ap-cd/ld   -   -   -   -   [1]
6 
 146   Ap09004   -   -   -   -   [1]
6 
 147   Apl-130277   -   -   -   -   [1]
6 
 148   Aplindore   Aplindore   -   -   -   [1]
6 
 149   Aplindore mr tablets   Aplindore   -   -   -   [1]
6 
 150   Apo-go   -   -   -   -   [1]
6 
 151   Apo-go®   -   -   -   -   [1]
6 
 152   Apokinon   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 153   Apokyn   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 154   Apomorphine   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 155   Apomorphine 0.25% (2.5mg/ml)   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 156   Apomorphine hcl injection   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 157   Apomorphine hydrochloride   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 158   Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 159   Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 160   Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 161   Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 162   Apomorphine hydrocloride   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 163   Apomorphine hydrocloride hemihydrate   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 164   Apomorphine infusion   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 165   Apomorphine nasal powder   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 166   Aqw051   -   -   -   -   [1]
6 
 167   Aricept   Donepezil   D00670, D07869   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [4]
6,
13,
78,
124 
 168   Aricept 5 mg-filmtabletten   -   -   -   -   [1]
6 
 169   Aricept 5mg-filmtabletten   -   -   -   -   [1]
6 
 170   Aripiprazole   Aripiprazole   D01164   [4] DRD2, DRD3, HTR1A, HTR2A   [12] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   [2]
6,
206 
 171   Armodafinil   Armodafinil   D03215   [1] SLC6A3   [6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   [3]
6,
13,
84 
 172   At 10   Dihydrotachysterol   D00299   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [1]
6 
 173   Atm fog in pd   -   -   -   -   [1]
6 
 174   Atomoxetine   Atomoxetine   D02574, D07473   [1] SLC6A2   [1] Synaptic vesicle cycle   [3]
6,
8,
13 
 175   Atypical antipsychotics   -   -   -   -   [1]
6 
 176   Autologous mesenchymal stem cells   -   -   -   -   [5]
2,
6,
13,
17,
46 
 177   Av-101   -   -   -   -   [1]
6 
 178   Avalox   Moxifloxacin   D00874, D08237   -   -   [1]
6 
 179   Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al   Moxifloxacin   D00874, D08237   -   -   [1]
6 
 180   Ave8112   -   -   -   -   [1]
6 
 181   Avp-923   -   -   -   -   [3]
2,
6,
13 
 182   Avp-923-45   -   -   -   -   [1]
6 
 183   Azd3241   -   -   -   -   [2]
6,
17 
 184   Azd3241 300 mg bid   -   -   -   -   [1]
6 
 185   Azd3241 600 mg bid   -   -   -   -   [1]
6 
 186   Azd3241 alternative titration scheme with formulation 1 or 2   -   -   -   -   [1]
6 
 187   Azd3241 er formulation 1   -   -   -   -   [1]
6 
 188   Azd3241 extended release tablets 100 mg   -   -   -   -   [1]
6 
 189   Azd3241 extended release tablets 25 mg   -   -   -   -   [1]
6 
 190   Azilect   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [3]
5,
6,
17 
 191   Azilect®   -   -   -   -   [1]
6 
 192   B-cit and spect imaging   -   -   -   -   [1]
6 
 193   B6, b12, l-methylfolate   Levomefolic acid   D09353   -   -   [1]
6 
 194   Balance   Isoxaflutole   -   -   -   [8]
5,
6,
13,
18,
81,
113,
149,
299 
 195   Bavisant   Bavisant   D09870   [1] HRH3   [1] Neuroactive ligand-receptor interaction   [1]
6 
 196   Bavisant dihydrochloride monohydrate   Bavisant   D09870   [1] HRH3   [1] Neuroactive ligand-receptor interaction   [1]
6 
 197   Bavisant hydrochloride monohydrate   Bavisant   D09870   [1] HRH3   [1] Neuroactive ligand-receptor interaction   [1]
6 
 198   Bee venom   -   -   -   -   [1]
6 
 199   Ben-2001   -   -   -   -   [1]
6 
 200   Benserazide   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 201   Benserazide hydrochloride   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 202   Benzofuran   Benzofuran   -   -   -   [1]
6 
 203   Best medical treatment   -   -   -   -   [1]
6 
 204   Bf 2.649   -   -   -   -   [1]
6 
 205   Bf2.649   -   -   -   -   [1]
6 
 206   Bf2.649 (pitolisant)   Pitolisant   D10749   [1] HRH3   [1] Neuroactive ligand-receptor interaction   [1]
6 
 207   Bi-sifrol®   -   -   -   -   [1]
6 
 208   Bia 3-202   -   -   -   -   [1]
6 
 209   Bia 3-202 (200 mg)   -   -   -   -   [1]
6 
 210   Bia 6-512   -   -   -   -   [1]
6 
 211   Bia 6-512 100 mg   -   -   -   -   [1]
6 
 212   Bia 6-512 100 mg dose   -   -   -   -   [1]
6 
 213   Bia 6-512 200 mg dose   -   -   -   -   [1]
6 
 214   Bia 6-512 25 mg   -   -   -   -   [1]
6 
 215   Bia 6-512 25 mg dose   -   -   -   -   [1]
6 
 216   Bia 6-512 400 mg   -   -   -   -   [1]
6 
 217   Bia 6-512 50 mg dose   -   -   -   -   [1]
6 
 218   Bia 9-1067   -   -   -   -   [1]
6 
 219   Bia 9-1067 (test)   -   -   -   -   [1]
6 
 220   Bia 9-1067 15 mg   -   -   -   -   [1]
6 
 221   Bia 9-1067 25 mg   -   -   -   -   [1]
6 
 222   Bia 9-1067 30 mg   -   -   -   -   [1]
6 
 223   Bia 9-1067 5 mg   -   -   -   -   [1]
6 
 224   Bia 9-1067 micronized   -   -   -   -   [1]
6 
 225   Bia 9-1067 non-micronized   -   -   -   -   [1]
6 
 226   Biib014   -   -   -   -   [1]
6 
 227   Biib054   -   -   -   -   [1]
6 
 228   Biib094   -   -   -   -   [1]
6 
 229   Bisphosphonates   -   -   -   -   [2]
6,
274 
 230   Bone marrow derived mesenchymal stem cells   -   -   -   -   [2]
6,
60 
 231   Bont-a   -   -   -   -   [1]
6 
 232   Botox   Botulinum toxin type a   D00783   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [4]
6,
13,
149,
226 
 233   Botulinum toxin   -   -   -   -   [1]
6 
 234   Botulinum toxin type a   Botulinum toxin type a   D00783   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [10]
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 235   Botulinum toxin type b   Botulinum toxin type b   D02735   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [3]
2,
6,
51 
 236   Botulinum toxin type b (myobloc)   Botulinum toxin type b   D02735   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [2]
2,
6 
 237   Botulinum toxin: xeomin   -   -   -   -   [1]
6 
 238   Bromocriptine   Bromocriptine   D00780, D03165   [2] DRD2, PRL   [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
74 
 239   Bromocriptine and other dopamine agonists   Bromocriptine   D00780, D03165   [2] DRD2, PRL   [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 240   Btrx-246040   -   -   -   -   [1]
6 
 241   Btx-a   Botulinum toxin type a   D00783   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [1]
6 
 242   Bumetanide   Bumetanide   D00247   [1] SLC12A2   [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection   [2]
6,
158 
 243   Bumetanide white, oblong, scored tablet   Bumetanide   D00247   [1] SLC12A2   [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection   [1]
6 
 244   Bupleurum+ginkgo   Ginkgo biloba   -   -   -   [1]
6 
 245   Buspirone   Buspirone   D00702, D07593   [2] DRD2, HTR1A   [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   [2]
6,
51 
 246   Buspirone hydrochloride   Buspirone   D00702, D07593   [2] DRD2, HTR1A   [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   [1]
6 
 247   Butylphthalide   Butylphthalide   -   -   -   [2]
2,
6 
 248   Byetta 5 micrograms   Exenatide   D04121   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
6 
 249   Cabaseril   Cabergoline   D00987   [2] DRD2, PRL   [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 250   Cabaseril, 1,0 mg tablette   Cabergoline   D00987   [2] DRD2, PRL   [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 251   Cabaseril, 2,0 mg tablette   Cabergoline   D00987   [2] DRD2, PRL   [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 252   Cabergoline   Cabergoline   D00987   [2] DRD2, PRL   [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   [3]
6,
74,
75 
 253   Caffeine   Caffeine   D00528, D01453   [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [6]
2,
6,
46,
78,
96,
97 
 254   Caffeine 100-200 mg bid   Caffeine   D00528, D01453   [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 255   Caffeine alkaloid   Caffeine   D00528, D01453   [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 256   Calcium   Calcium   -   -   -   [24]
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 257   Cannabidiol   Cannabidiol   D10915   [2] CNR1, CNR2   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [13]
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 258   Cannabis   Medical cannabis   -   -   -   [6]
2,
6,
13,
90,
96,
97 
 259   Cannabis oil   Medical cannabis   -   -   -   [1]
6 
 260   Cannabis, medical   Medical cannabis   -   -   -   [5]
2,
6,
13,
96,
97 
 261   Capsaicin   Capsaicin   D00250   [1] TRPV1   [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   [6]
2,
6,
19,
86,
113,
226 
 262   Capsaicin vapor   Capsaicin   D00250   [1] TRPV1   [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   [1]
6 
 263   Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 264   Capture   Bifenthrin   -   -   -   [2]
6,
46 
 265   Carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [8]
2,
4,
6,
13,
17,
90,
164,
201 
 266   Carbidopa 20 mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 267   Carbidopa 27.5 mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 268   Carbidopa 65 mg capsule   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 269   Carbidopa and levodopa 25mg/100mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 270   Carbidopa fu   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 271   Carbidopa levodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 272   Carbidopa monohydrate   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 273   Carbidopa, levodopa, entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 274   Carbidopa- levodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 275   Carbidopa-levodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [3]
2,
4,
6 
 276   Carbidopa/l-dopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 277   Carbidopa/l-dopa/entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 278   Carbidopa/levodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 279   Carbidopa/levodopa, immediate release   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 280   Carbidopa/levodopa/entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 281   Carbon   Activated charcoal   D03251   -   -   [7]
6,
46,
85,
86,
96,
97,
298 
 282   Carnosine   Carnosine   -   -   -   [2]
6,
13 
 283   Carnosine supplementation   Carnosine   -   -   -   [1]
6 
 284   Carvedilol   Carvedilol   D00255, D03415   [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   [12] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [4]
6,
57,
86,
113 
 285   Catapres ampoules   Clonidine   D00281, D00604   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
6 
 286   Cd-ld cr   -   -   -   -   [1]
6 
 287   Cd-ld ir   -   -   -   -   [1]
6 
 288   Cdnf   -   -   -   -   [1]
6 
 289   Ceftriaxone   Ceftriaxone   D00924, D07659   -   -   [3]
2,
6,
97 
 290   Cep-1347   -   -   -   -   [1]
6 
 291   Cep-1347 10mg   -   -   -   -   [1]
6 
 292   Cep-1347 50mg   -   -   -   -   [1]
6 
 293   Cep1347   Cep1347   -   -   -   [1]
6 
 294   Cep1347 25mg   Cep1347   -   -   -   [1]
6 
 295   Cere-120   -   -   -   -   [1]
6 
 296   Cere-120: adeno-associated virus delivery of neurturin   -   -   -   -   [1]
6 
 297   Cerebral dopamine neurotrophic factor   Dopamine   D00633, D07870   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 298   Ceretec   Technetium tc-99m exametazime   D02284   -   -   [1]
6 
 299   Ceretec (tm) estabilizado   Technetium tc-99m exametazime   D02284   -   -   [1]
6 
 300   Champix   Varenicline   D08669   [2] CHRNA4, CHRNB2   [3] Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 301   Chloride   Chloride ion   -   -   -   [17]
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 302   Chocolate   Cocoa   -   -   -   [1]
6 
 303   Cipralex   -   -   -   -   [1]
6 
 304   Cjh1 (clr4001)   -   -   -   -   [1]
6 
 305   Clarithromycin   Clarithromycin   D00276   -   -   [8]
6,
63,
84,
96,
97,
222,
228,
299 
 306   Clarium   Loratadine   D00364   [1] HRH1   [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   [1]
6 
 307   Clarium 50 mg retardtabletten   Loratadine   D00364   [1] HRH1   [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   [1]
6 
 308   Clartihromycin, amoxicillin, and omeprazole   Amoxicillin   D00229, D02925, D07452   -   -   [1]
6 
 309   Clonazepam   Clonazepam   D00280   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
6 
 310   Clonidine   Clonidine   D00281, D00604   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [2]
6,
78 
 311   Clonidine hydrochloride   Clonidine   D00281, D00604   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [2]
6,
78 
 312   Clozapine   Clozapine   D00283   [11] ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E   [8] Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway   [1]
6 
 313   Cocoa   Cocoa   -   -   -   [1]
6 
 314   Coenzyme q10   Ubidecarenone   D01065   -   -   [10]
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 315   Coenzyme q10 nanodispersion (nanoquinone)   Ubidecarenone   D01065   -   -   [1]
6 
 316   Coenzyme q10 with vitamin e   Vitamin e   D02331   -   -   [1]
6 
 317   Cogane™ (pym50028)   -   -   -   -   [1]
6 
 318   Cohort 1:nilotinib oral capsules (150mg or 300mg)   Nilotinib   D08953   [4] ABL1, KIT, PDGFRA, PDGFRB   [33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   [1]
6 
 319   Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1)   Nilotinib   D08953   [4] ABL1, KIT, PDGFRA, PDGFRB   [33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   [1]
6 
 320   Combination injection of epo and g-csf   Filgrastim   D03235   [1] CSF3R   [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   [1]
6 
 321   Comparator: carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 322   Comparator: levodopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 323   Comtan   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 324   Comtan®   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 325   Comtess   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 326   Comtess®   -   -   -   -   [1]
6 
 327   Continuous intrajejunal infusion of levodopa-carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 328   Continuous release dopamine agonists   Dopamine   D00633, D07870   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 329   Control   Chloroxylenol   D03473   -   -   [4]
6,
13,
46,
168 
 330   Controlled-release levodopa / carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 331   Coq10   Ubidecarenone   D01065   -   -   [3]
5,
6,
8 
 332   Creatine   Creatine   -   -   -   [12]
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 333   Cu(ii)atsm   -   -   -   -   [2]
2,
6 
 334   Cvd00118-e   -   -   -   -   [1]
6 
 335   Cvt-301   -   -   -   -   [1]
6 
 336   Cvt-301 (dose level 1)   -   -   -   -   [1]
6 
 337   Cvt-301 (dose level 2)   -   -   -   -   [1]
6 
 338   Cvt-301 35mg   -   -   -   -   [1]
6 
 339   Cvt-301 50mg   -   -   -   -   [1]
6 
 340   Cvt-301 high dose   -   -   -   -   [1]
6 
 341   Cvt-301 low dose   -   -   -   -   [1]
6 
 342   Cvt-301, lip   -   -   -   -   [1]
6 
 343   Cvxl-0107   -   -   -   -   [1]
6 
 344   Cx-8998   -   -   -   -   [1]
6 
 345   Cyberknife   -   -   -   -   [1]
6 
 346   Cymbalta   Duloxetine   D01179, D07880   [2] SLC6A2, SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [3]
6,
13,
49 
 347   Cysteine   L-cysteine   D00026, D02326   -   -   [9]
6,
13,
19,
84,
85,
88,
90,
254,
296 
 348   Cystoscopic injection of botox into the urinary bladder   -   -   -   -   [1]
6 
 349   D-serine   Serine   D00016   -   -   [1]
6 
 350   D-serine (~2g/day)   Serine   D00016   -   -   [1]
6 
 351   Da-9701   -   -   -   -   [1]
6 
 352   Da-9805 45mg   -   -   -   -   [1]
6 
 353   Da-9805 90mg   -   -   -   -   [1]
6 
 354   Dacepton 5 mg/ml   -   -   -   -   [1]
6 
 355   Dacepton 5 mg/ml infuusioneste, liuos   -   -   -   -   [1]
6 
 356   Darifenacin   Darifenacin   D01699, D03654   [1] CHRM3   [9] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   [2]
6,
13 
 357   Dark chocolate (85% cocoa)   Cocoa   -   -   -   [1]
6 
 358   Date   Date   -   -   -   [3]
6,
88,
113 
 359   Datscan   Ioflupane i-123   D10014   -   -   [3]
2,
5,
6 
 360   Datscan™   -   -   -   -   [1]
6 
 361   Dc158am   -   -   -   -   [1]
6 
 362   Deanol   Deanol   D07777   -   -   [1]
6 
 363   Deanol pyroglutamate   Deanol   D07777   -   -   [1]
6 
 364   Debrumyl   -   -   -   -   [1]
6 
 365   Deferiprone   Deferiprone   D07416   -   -   [5]
2,
6,
120,
122,
233 
 366   Deferiprone (ferriprox)   Deferiprone   D07416   -   -   [1]
6 
 367   Deferiprone 600 mg delayed release tablet   Deferiprone   D07416   -   -   [1]
6 
 368   Desmopressin   Desmopressin   D00291, D02235   [2] AVPR2, F8   [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption   [5]
6,
64,
72,
225,
288 
 369   Desmopressin acetat   Desmopressin   D00291, D02235   [2] AVPR2, F8   [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption   [1]
6 
 370   Desmotabs   -   -   -   -   [1]
6 
 371   Desmotabs® 0,2 mg tabletten   -   -   -   -   [1]
6 
 372   Desmotabs® 0,2mg tabletten   -   -   -   -   [1]
6 
 373   Dexdor   -   -   -   -   [4]
2,
4,
6,
70 
 374   Dexmedetomidina   Dexmedetomidine   D00514, D01205   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
6 
 375   Dexmedetomidine   Dexmedetomidine   D00514, D01205   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [11]
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 376   Dexmedetomidine hydrochloride infusion   Dexmedetomidine   D00514, D01205   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
6 
 377   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [9]
2,
6,
8,
13,
46,
78,
96,
97,
156 
 378   Different diets   -   -   -   -   [1]
6 
 379   Dihydroergotoxine mesylate   Ergoloid mesylate   D02268   [6] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C   [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
6 
 380   Dipivefrin   Dipivefrin   D02349   [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 381   Dipivefrine   Dipivefrin   D02349   [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 382   Dipraglurant   Dipraglurant   -   -   -   [1]
6 
 383   Ditropan elixir   Oxybutynin   D00465, D00722   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 384   Dm-1992   -   -   -   -   [1]
6 
 385   Dnl151 high dose   -   -   -   -   [1]
6 
 386   Dnl151 low dose   -   -   -   -   [1]
6 
 387   Dnl201 high dose   -   -   -   -   [1]
6 
 388   Dnl201 low dose   -   -   -   -   [1]
6 
 389   Dns-7801 (high dose)   -   -   -   -   [1]
6 
 390   Dns-7801 (low-dose)   -   -   -   -   [1]
6 
 391   Docosahexaenoic acid   Doconexent   -   -   -   [7]
6,
49,
90,
94,
240,
299,
301 
 392   Docosahexaenoic acid (dha)   Doconexent   -   -   -   [3]
6,
94,
299 
 393   Domperidone   Domperidone   D01745, D07868   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [5]
6,
13,
17,
51,
230 
 394   Domperidone (drug)   Domperidone   D01745, D07868   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 395   Dompéridone   -   -   -   -   [1]
6 
 396   Donepezil   Donepezil   D00670, D07869   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [9]
5,
6,
13,
46,
78,
124,
127,
156,
206 
 397   Donepezil sandoz   Donepezil   D00670, D07869   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [1]
6 
 398   Dopamine   Dopamine   D00633, D07870   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [3]
6,
7,
74 
 399   Dopamine agent   Dopamine   D00633, D07870   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 400   Dopamine agonists (pramipexole, ropirinole)   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 401   Dopaminergic agonist + apomorphine   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 402   Dopaminergic agonists   -   -   -   -   [1]
6 
 403   Dops   Droxidopa   D01277   [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [2]
6,
17 
 404   Doxepin   Doxepin   D00814, D07875   [3] HRH1, SLC6A2, SLC6A4   [5] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle   [1]
6 
 405   Doxepin and zopiclone   Zopiclone   D01372   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
6 
 406   Dpa-714-pet/mri   -   -   -   -   [1]
6 
 407   Droxidopa   Droxidopa   D01277   [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [3]
5,
6,
17 
 408   Duloxetine   Duloxetine   D01179, D07880   [2] SLC6A2, SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [2]
6,
13 
 409   Duloxetine hydrochloride   Duloxetine   D01179, D07880   [2] SLC6A2, SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [1]
6 
 410   Duodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 411   Duodopa intestinal gel   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 412   Duodopa ld/cd 20/5 mg/ml   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 413   Dynacirc cr (isradipine)   Isradipine   D00349   [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S   [34] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 414   E2007   -   -   -   -   [2]
6,
144 
 415   Ebixa   Memantine   D04905, D08174   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [3]
2,
6,
13 
 416   Ebixa®   -   -   -   -   [1]
6 
 417   Egcg   Epigallocatechin gallate   -   -   -   [8]
6,
13,
17,
28,
85,
113,
206,
299 
 418   Elc200   -   -   -   -   [1]
6 
 419   Eliprodil   Eliprodil   -   -   -   [1]
6 
 420   Eltoprazine   Eltoprazine   -   -   -   [1]
6 
 421   Eltoprazine hcl   Eltoprazine   -   -   -   [1]
6 
 422   Eltoprazine hydrochloride   Eltoprazine   -   -   -   [1]
6 
 423   Emd 128130   -   -   -   -   [2]
6,
156 
 424   Emd128130   -   -   -   -   [1]
6 
 425   Ent-01   -   -   -   -   [1]
6 
 426   Entacapon   -   -   -   -   [1]
6 
 427   Entacapona   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 428   Entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [2]
6,
17 
 429   Entacapone and carbidopa   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 430   Epi-589   -   -   -   -   [2]
2,
6 
 431   Epi-743 200mg   -   -   -   -   [1]
6 
 432   Epi-743 400mg   -   -   -   -   [1]
6 
 433   Er cd-ld   -   -   -   -   [1]
6 
 434   Er tablet 100 mg azd3241   -   -   -   -   [1]
6 
 435   Er tablet 25 mg azd3241   -   -   -   -   [1]
6 
 436   Eradication of helcobacter pylori   -   -   -   -   [1]
6 
 437   Eradication therapy for h.pylori infection   -   -   -   -   [1]
6 
 438   Eradication therapy for helicobacter pylori   -   -   -   -   [1]
6 
 439   Erythromycin   Erythromycin   D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054   -   -   [5]
6,
36,
164,
228,
291 
 440   Erythropoietin   Erythropoietin   D03231   [1] EPOR   [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   [8]
2,
6,
13,
22,
47,
70,
95,
96 
 441   Erythropoietin human recombinant (eporh)   Erythropoietin   D03231   [1] EPOR   [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   [1]
6 
 442   Escitalopram   Escitalopram   D02567, D07704, D07913   [1] SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [3]
2,
6,
13 
 443   Esomeprazole   Esomeprazole   D01984, D04056, D07917, D09339   [2] ATP4A, ATP4B   [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   [6]
6,
46,
86,
98,
298,
299 
 444   Eszopiclone   Eszopiclone   D02624   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [3]
6,
13,
46 
 445   Ethnodyne visio   -   -   -   -   [1]
6 
 446   Exametazime   Exametazime   D01109   -   -   [1]
6 
 447   Exelon   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [2]
6,
13 
 448   Exelon 4.6 mg/24 h transdermal patch   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [1]
6 
 449   Exelon 9.5 mg/24 h transdermal patch   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [1]
6 
 450   Exelon patch (rivastigmine transdermal system)   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [1]
6 
 451   Exenatide   Exenatide   D04121   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [3]
6,
193,
233 
 452   Exenatide 10 micrograms   Exenatide   D04121   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
6 
 453   Exenatide 5 micrograms   Exenatide   D04121   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
6 
 454   F-18 fpcit   -   -   -   -   [1]
6 
 455   Famotidine   Famotidine   D00318   [1] HRH2   [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   [3]
6,
46,
86 
 456   Febuxostat   Febuxostat   D01206   [1] XDH   [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   [3]
2,
6,
13 
 457   Ferrprox (deferiprone)   Deferiprone   D07416   -   -   [1]
6 
 458   Fesoterodine   Fesoterodine   D07226   [2] CHRM2, CHRM3   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 459   Fetal porcine cells, neurocell-pd   -   -   -   -   [1]
6 
 460   Filgrastim   Filgrastim   D03235   [1] CSF3R   [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   [25]
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 461   Finasteride   Finasteride   D00321   [1] SRD5A2   [2] Prostate cancer, Steroid hormone biosynthesis   [1]
6 
 462   Fipamezole   Fipamezole   -   -   -   [2]
6,
17 
 463   Fipamezole hydrochloride   Fipamezole   -   -   -   [2]
6,
17 
 464   Fipamezole hydrochloride 30 mg oral disintegrating tablets   Fipamezole   -   -   -   [2]
6,
17 
 465   Fipamezole hydrochloride 60 mg oral disintegrating tablets   Fipamezole   -   -   -   [2]
6,
17 
 466   Fipamezole hydrochloride 90 mg oral disintegrating tablets   Fipamezole   -   -   -   [2]
6,
17 
 467   Fipamezole odt   Fipamezole   -   -   -   [1]
6 
 468   Fipamezole odt cohort 2   Fipamezole   -   -   -   [1]
6 
 469   Flecainide   Flecainide   D00638, D07962   [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   [1]
6 
 470   Flecainide acetate   Flecainide   D00638, D07962   [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   [1]
6 
 471   Flecainidum   Flecainide   D00638, D07962   [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   [1]
6 
 472   Florbetaben (18f)   -   -   -   -   [1]
6 
 473   Florbetapir f 18   -   -   -   -   [1]
6 
 474   Fludrocortisone   Fludrocortisone   D00986, D07967   [1] NR3C2   [1] Aldosterone-regulated sodium reabsorption   [3]
6,
17,
81 
 475   Flumazenil   Flumazenil   D00697   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [5]
6,
13,
17,
18,
206 
 476   Flutemetamol   Flutemetamol   -   -   -   [5]
5,
6,
7,
17,
127 
 477   Folic acid   Folic acid   D00070   -   -   [4]
6,
46,
49,
84 
 478   Folic acid, vitamin b6, vitamin b12   Folic acid   D00070   -   -   [1]
6 
 479   Foliglurax   Foliglurax   -   -   -   [1]
6 
 480   Fpf1100nw   -   -   -   -   [1]
6 
 481   Fpfs-1169   -   -   -   -   [1]
6 
 482   Fursultiamine   Fursultiamine   D03319   -   -   [1]
6 
 483   G-csf   Filgrastim   D03235   [1] CSF3R   [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   [12]
6,
13,
16,
49,
51,
60,
65,
85,
96,
284,
285,
331 
 484   Gabapentin   Gabapentin   D00332   [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   [5]
6,
13,
19,
70,
298 
 485   Gabapentina   Gabapentin   D00332   [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   [1]
6 
 486   Gabapentina kern pharma   Gabapentin   D00332   [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   [1]
6 
 487   Galantamine   Galantamine   D02173, D04292   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [2]
6,
127 
 488   Ganoderma   -   -   -   -   [1]
6 
 489   Ghrelin   Lenomorelin   -   -   -   [3]
6,
78,
299 
 490   Ginkgo   Ginkgo biloba   -   -   -   [3]
6,
13,
90 
 491   Glial cell line-derived neurotrophic factor   -   -   -   -   [1]
6 
 492   Glial cell line-derived neurotrophic factor (gdnf)   -   -   -   -   [1]
6 
 493   Glucose   D-glucose   D00009   -   -   [3]
6,
13,
299 
 494   Glutathione   Glutathione   D00014, D00031   -   -   [2]
6,
299 
 495   Glycerol   Glycerin   D00028   -   -   [4]
6,
13,
316,
317 
 496   Glycerol phenylbutyrate   Glycerol phenylbutyrate   D10127   -   -   [1]
6 
 497   Glycopyrrolate   Glycopyrronium   D00540, D10938   [1] CHRM3   [9] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   [1]
6 
 498   Gm1 ganglioside   -   -   -   -   [1]
6 
 499   Gm608   -   -   -   -   [1]
6 
 500   Gold   Gold   -   -   -   [5]
2,
6,
13,
46,
171 
 501   Gold nanocrystals   Gold   -   -   -   [3]
2,
6,
13 
 502   Gpi 1485   -   -   -   -   [1]
6 
 503   Grapefruit   Grapefruit   -   -   -   [5]
6,
46,
50,
83,
97 
 504   Green tea   Green tea leaf   D06903   -   -   [5]
6,
17,
28,
46,
96 
 505   Green tea polyphenols (egcg/ecg)   Green tea leaf   D06903   -   -   [1]
6 
 506   Grf6021   -   -   -   -   [1]
6 
 507   Group ad anti-pd + antidepressant   -   -   -   -   [1]
6 
 508   Group r rasagiline   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 509   Group r+ad rasagiline + antidepressant   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 510   Gsk962040   -   -   -   -   [1]
6 
 511   Gsk962040 (25 mg tablet)   -   -   -   -   [1]
6 
 512   Gz/sar402671   -   -   -   -   [2]
6,
19 
 513   Hb-admsc   -   -   -   -   [2]
6,
46 
 514   Helicobacter pylori eradication therapy   -   -   -   -   [1]
6 
 515   Heptaminol   Heptaminol   D07158   -   -   [1]
6 
 516   Heptaminol hydrochloride   Heptaminol   D07158   -   -   [1]
6 
 517   Herbal medicinal mixture (roucongrong, heshouwu etc.)   Reynoutria multiflora root   -   -   -   [1]
6 
 518   Heshouwu   Reynoutria multiflora root   -   -   -   [1]
6 
 519   Hf0220   -   -   -   -   [1]
6 
 520   High dose affitope® pd03a + adjuvant   -   -   -   -   [1]
6 
 521   High dose anavex2-73   -   -   -   -   [1]
6 
 522   High protein. t-diet plus range   -   -   -   -   [1]
6 
 523   Hp-3000 (ropinirole hydrochloride patch)   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 524   Hp-3000 placebo   -   -   -   -   [1]
6 
 525   Hp-3000(ropinirole hydrochloride patch)   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 526   Human neural stem cell   -   -   -   -   [1]
6 
 527   Human stem cells   -   -   -   -   [1]
6 
 528   Hydrocortisone   Hydrocortisone   D00088   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [8]
6,
53,
75,
78,
81,
83,
97,
299 
 529   Hydrocortisone cream   Hydrocortisone   D00088   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
6 
 530   Hydrocortisone cream 1%   Hydrocortisone   D00088   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
6 
 531   Hydrocortisone cream 10mg/g fna fagron   Hydrocortisone   D00088   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
6 
 532   Hydrogen   Hydrogen   -   -   -   [5]
5,
6,
17,
97,
226 
 533   I 123   Iodide i-123   -   -   -   [1]
6 
 534   I-123   Iodide i-123   -   -   -   [2]
2,
6 
 535   I-123-5-ia85380   Iodide i-123   -   -   -   [1]
6 
 536   Iberogast   -   -   -   -   [1]
6 
 537   Idebenone   Idebenone   D01750   -   -   [4]
6,
13,
113,
302 
 538   Immediate release carbidopa/levodopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 539   Immediate release carbidopa/levodopa 25/100 mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 540   Impact   Topramezone   -   -   -   [7]
6,
13,
46,
50,
96,
97,
299 
 541   Incobotulinum toxin a   -   -   -   -   [2]
2,
6 
 542   Incobotulinumtoxina   Botulinum toxin type a   D00783   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [1]
6 
 543   Infudopa i.v.   -   -   -   -   [1]
6 
 544   Infudopa s.c.   -   -   -   -   [1]
6 
 545   Infusions of young plasma   -   -   -   -   [1]
6 
 546   Inhaled vr040   -   -   -   -   [1]
6 
 547   Injection of apomorphine   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 548   Injection of normal saline   -   -   -   -   [1]
6 
 549   Injection of umbilical cord derived mscs   -   -   -   -   [1]
6 
 550   Inosine   Inosine   D00054   -   -   [4]
2,
6,
13,
17 
 551   Intracerebral microinjections   -   -   -   -   [1]
6 
 552   Intranasal glutathione - (in)gsh   Glutathione   D00014, D00031   -   -   [1]
6 
 553   Intranasal insulin   -   -   -   -   [2]
6,
17 
 554   Intravenous and oral n—acetyl cysteine   L-cysteine   D00026, D02326   -   -   [1]
6 
 555   Intravenous infusion   -   -   -   -   [1]
6 
 556   Intravenous levodopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 557   Intravesical injection of botulinum a toxin   -   -   -   -   [2]
6,
17 
 558   Ioflupane (123i)   Ioflupane i-123   D10014   -   -   [1]
6 
 559   Ioflupane 123i (datscan®)   -   -   -   -   [1]
6 
 560   Ioflupane [123 i]   Ioflupane i-123   D10014   -   -   [1]
6 
 561   Ioflupane i 123   Ioflupane i-123   D10014   -   -   [1]
6 
 562   Ipratropium   Ipratropium   D02212   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [2]
6,
86 
 563   Ipratropium bromide (drug)   Ipratropium   D02212   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 564   Iproniazid   Iproniazid   D02579   [2] MAOA, MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 565   Ips-nsc cells   -   -   -   -   [1]
6 
 566   Ipt803   -   -   -   -   [1]
6 
 567   Ipx054 100 mg   -   -   -   -   [1]
6 
 568   Ipx054 150 mg   -   -   -   -   [1]
6 
 569   Ipx054 200 mg   -   -   -   -   [1]
6 
 570   Ipx054 250 mg   -   -   -   -   [1]
6 
 571   Ipx054 300 mg   -   -   -   -   [1]
6 
 572   Ipx066   -   -   -   -   [1]
6 
 573   Ipx066 145 mg   -   -   -   -   [1]
6 
 574   Ipx066 145 mg ld   -   -   -   -   [1]
6 
 575   Ipx066 195 mg   -   -   -   -   [1]
6 
 576   Ipx066 195 mg ld   -   -   -   -   [1]
6 
 577   Ipx066 245 mg   -   -   -   -   [1]
6 
 578   Ipx066 245 mg ld   -   -   -   -   [1]
6 
 579   Ipx066 95 mg   -   -   -   -   [1]
6 
 580   Ipx066 95 mg ld   -   -   -   -   [1]
6 
 581   Ipx066-145   -   -   -   -   [1]
6 
 582   Ipx066-195   -   -   -   -   [1]
6 
 583   Ipx066-245   -   -   -   -   [1]
6 
 584   Ipx066-95   -   -   -   -   [1]
6 
 585   Ipx203 140 mg   -   -   -   -   [1]
6 
 586   Ipx203 180 mg   -   -   -   -   [1]
6 
 587   Ipx203 210 mg   -   -   -   -   [1]
6 
 588   Ipx203 270 mg   -   -   -   -   [1]
6 
 589   Ipx203 280 mg   -   -   -   -   [1]
6 
 590   Ipx203 350 mg   -   -   -   -   [1]
6 
 591   Ipx203 er cd-ld   -   -   -   -   [1]
6 
 592   Ir cd-ld   -   -   -   -   [1]
6 
 593   Irl752   -   -   -   -   [1]
6 
 594   Irl790   -   -   -   -   [1]
6 
 595   Irx4204   -   -   -   -   [1]
6 
 596   Isc-hpnsc   -   -   -   -   [1]
6 
 597   Isicom   -   -   -   -   [1]
6 
 598   Isoflurane   Isoflurane   D00545   -   -   [1]
6 
 599   Isradipine   Isradipine   D00349   [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S   [34] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 600   Isradipine cr 10mg   Isradipine   D00349   [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S   [34] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 601   Isradipine cr 20mg   Isradipine   D00349   [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S   [34] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 602   Isradipine cr 5mg   Isradipine   D00349   [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S   [34] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 603   Istradefylline   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 604   Istradefylline ( kw-6002)   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 605   Istradefylline (kw-6002)   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 606   Istradefylline 20 mg   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 607   Istradefylline 20 mg or 40 mg   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 608   Istradefylline 40 mg   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 609   Iti-214   -   -   -   -   [1]
6 
 610   Iv apomorphine   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 611   Iv levodopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 612   Jm-010   -   -   -   -   [1]
6 
 613   Jm-010 a group   -   -   -   -   [1]
6 
 614   Jm-010 b group   -   -   -   -   [1]
6 
 615   Jnj-31001074   -   -   -   -   [1]
6 
 616   Jp 1730   -   -   -   -   [1]
6 
 617   Jp-1730/f01   -   -   -   -   [2]
6,
17 
 618   Jp-1730/f02   -   -   -   -   [2]
6,
17 
 619   Jp-1730/f03   -   -   -   -   [2]
6,
17 
 620   Jzp-110   -   -   -   -   [1]
6 
 621   K0706   -   -   -   -   [1]
6 
 622   Kdt-3594   -   -   -   -   [1]
6 
 623   Ketone ester drink   -   -   -   -   [1]
6 
 624   Kinoquinone (proposed)   -   -   -   -   [1]
6 
 625   Km-819   -   -   -   -   [1]
6 
 626   Kw-6002   -   -   -   -   [1]
6 
 627   Kw-6002 (istradefylline)   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 628   Kw-6356   -   -   -   -   [1]
6 
 629   Kw-6356 high dose   -   -   -   -   [1]
6 
 630   Kw-6356 low dose   -   -   -   -   [1]
6 
 631   Kw-6356 middle dose   -   -   -   -   [1]
6 
 632   Kw-6356 x dose   -   -   -   -   [1]
6 
 633   Kw-6356 y dose   -   -   -   -   [1]
6 
 634   Kw-6500   -   -   -   -   [1]
6 
 635   L-123 ioflupane   -   -   -   -   [1]
6 
 636   L-dopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 637   L-dopa/ modopar   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 638   L-dops   Droxidopa   D01277   [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 639   L-methylfolate   Levomefolic acid   D09353   -   -   [1]
6 
 640   L-tyrosine   Tyrosine   D00022   -   -   [2]
6,
111 
 641   Lactobacillus plantarum   Lactobacillus plantarum   -   -   -   [2]
6,
156 
 642   Lactobacillus plantarum ps128   Lactobacillus plantarum   -   -   -   [1]
6 
 643   Lactose   Lactose   D00046, D03226   -   -   [6]
2,
6,
13,
97,
228,
310 
 644   Lcig   -   -   -   -   [1]
6 
 645   Lcig (duodopa)   -   -   -   -   [1]
6 
 646   Ld / be   -   -   -   -   [1]
6 
 647   Ld+ddci   -   -   -   -   [1]
6 
 648   Ld-ddci   -   -   -   -   [1]
6 
 649   Ld/cd   -   -   -   -   [1]
6 
 650   Leptin   Leptin   -   -   -   [2]
6,
265 
 651   Leucine   L-leucine   D00030   -   -   [7]
5,
6,
7,
127,
283,
284,
299 
 652   Levetiracetam   Levetiracetam   D00709   [1] SV2A   [1] ECM-receptor interaction   [4]
2,
4,
6,
13 
 653   Levodopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [7]
2,
4,
6,
17,
90,
164,
201 
 654   Levodopa (delivered intravenously)   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 655   Levodopa (drug), intraduodenal administration   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 656   Levodopa (l-dopa)   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 657   Levodopa (l-dopa) + standard care   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 658   Levodopa / benserazid   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 659   Levodopa / benserazide 200 + 50 mg   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 660   Levodopa 100 mg / benserazide 25 mg   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 661   Levodopa 100 mg a cap   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 662   Levodopa 125 mg a cap   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 663   Levodopa 150 mg a cap   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 664   Levodopa 25mg/100mg   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 665   Levodopa 75 mg a cap   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 666   Levodopa acute challenge   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 667   Levodopa and carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 668   Levodopa and carbidopa sc solution   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 669   Levodopa and carbidopa solution for sc administration   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 670   Levodopa and decarboxylase inhibitor   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 671   Levodopa and domperidone   Domperidone   D01745, D07868   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 672   Levodopa benserazide madopar   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 673   Levodopa benserazide teva italia   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 674   Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 675   Levodopa carbidopa intestinal gel (lcig)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 676   Levodopa cr (controlled release)   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 677   Levodopa cyclops   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 678   Levodopa dc.it fu   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 679   Levodopa dispersible   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 680   Levodopa infusion   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 681   Levodopa mr   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 682   Levodopa powder for inhalation   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 683   Levodopa, carbidopa, entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 684   Levodopa, carbidopa, odm-104   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 685   Levodopa, decarboxylase inhibitor and comt inhibitor   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 686   Levodopa-carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [2]
6,
90 
 687   Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 688   Levodopa-carbidopa immediate release (lc-ir) tablets   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 689   Levodopa-carbidopa intestinal gel   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 690   Levodopa-carbidopa multilayer extended release tablet   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 691   Levodopa-carbidopa xl tablet (m)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 692   Levodopa-carbidopa-entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 693   Levodopa/benserazide   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 694   Levodopa/benserazide 100/25 mg   Benserazide   D03082   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 695   Levodopa/benzeraside   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 696   Levodopa/benzerazide   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 697   Levodopa/carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [2]
6,
164 
 698   Levodopa/carbidopa (sinemet)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 699   Levodopa/carbidopa 100/25   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 700   Levodopa/carbidopa hydrate   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 701   Levodopa/carbidopa solution   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 702   Levodopa/carbidopa(200mg/50mg)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 703   Levodopa/carbidopa/entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 704   Levodopa/ddci   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 705   Liatermin   Liatermin   D04727   -   -   [1]
6 
 706   Liatermin (r-methugdnf)   Liatermin   D04727   -   -   [1]
6 
 707   Lidocaine   Lidocaine   D00358, D02086, D08127   [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   [8]
6,
13,
46,
86,
168,
226,
231,
256 
 708   Lingzhi (ganoderma)   -   -   -   -   [1]
6 
 709   Liraglutide   Liraglutide   D06404   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [3]
6,
75,
193 
 710   Lisparin   -   -   -   -   [1]
6 
 711   Lisuride   Lisuride   D01462, D08132   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
86 
 712   Lisuride hydrogenmaleate   Lisuride   D01462, D08132   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 713   Lisuride transdermal system   Lisuride   D01462, D08132   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 714   Lisuride tts 10cm²   Lisuride   D01462, D08132   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 715   Lisuride tts 20cm²   Lisuride   D01462, D08132   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 716   Lixisenatide   Lixisenatide   D09729   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
6 
 717   Local anesthesia (lidocaine hydrochloride)   Lidocaine   D00358, D02086, D08127   [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   [1]
6 
 718   Lodalès®   -   -   -   -   [1]
6 
 719   Lodosyn®   -   -   -   -   [1]
6 
 720   Lovastatin   Lovastatin   D00359   [1] HMGCR   [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   [10]
6,
34,
46,
79,
156,
160,
195,
206,
263,
310 
 721   Low dose affitope® pd03a + adjuvant   -   -   -   -   [1]
6 
 722   Lu 00-800   -   -   -   -   [1]
6 
 723   Lu ae04621   -   -   -   -   [1]
6 
 724   Lu af82422   -   -   -   -   [1]
6 
 725   Lubiprostone   Lubiprostone   D04790   [1] CLCN2   [1] Mineral absorption   [4]
6,
13,
290,
299 
 726   Ly03003   -   -   -   -   [1]
6 
 727   Ly300164   -   -   -   -   [1]
6 
 728   Ly3154207   -   -   -   -   [1]
6 
 729   Madopar   -   -   -   -   [1]
6 
 730   Madopar 125 mg, orodispersible tablet   -   -   -   -   [1]
6 
 731   Madopar 200+50 mg   -   -   -   -   [1]
6 
 732   Madopar lt   -   -   -   -   [1]
6 
 733   Madopar® 125   -   -   -   -   [1]
6 
 734   Madopar® 250   -   -   -   -   [1]
6 
 735   Madopar® hbs   -   -   -   -   [1]
6 
 736   Madopar® hbs 125   -   -   -   -   [1]
6 
 737   Magnesium   Magnesium   -   -   -   [15]
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 738   Magnesium oxide   Magnesium oxide   D01167   -   -   [3]
6,
166,
291 
 739   Maltodextrin   Maltodextrin   D02329   -   -   [4]
6,
13,
96,
97 
 740   Mannitol   Mannitol   D00062   -   -   [3]
6,
96,
299 
 741   Mantadix   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 742   Mars   -   -   -   -   [1]
6 
 743   Masitinib   Masitinib   D10229   [1] KIT   [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   [6]
2,
5,
6,
13,
46,
96 
 744   Masitinib mesylate   Masitinib   D10229   [1] KIT   [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway   [6]
2,
5,
6,
13,
46,
96 
 745   Me2125   -   -   -   -   [1]
6 
 746   Medi1341   -   -   -   -   [1]
6 
 747   Melatonin   Melatonin   D08170   [2] MTNR1A, MTNR1B   [2] Circadian entrainment, Neuroactive ligand-receptor interaction   [8]
6,
13,
46,
49,
90,
97,
144,
202 
 748   Melatonin pr   Melatonin   D08170   [2] MTNR1A, MTNR1B   [2] Circadian entrainment, Neuroactive ligand-receptor interaction   [1]
6 
 749   Melatonin(circadin®)   Melatonin   D08170   [2] MTNR1A, MTNR1B   [2] Circadian entrainment, Neuroactive ligand-receptor interaction   [1]
6 
 750   Melevodopa   Melevodopa   D07304   -   -   [1]
6 
 751   Melevodopa and decarboxylase inhibitor   Melevodopa   D07304   -   -   [1]
6 
 752   Melperon   -   -   -   -   [1]
6 
 753   Melperone   Melperone   D07309   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 754   Melperone hcl   Melperone   D07309   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 755   Memantin   Memantine   D04905, D08174   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 756   Memantin orion   Memantine   D04905, D08174   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 757   Memantine   Memantine   D04905, D08174   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [7]
2,
6,
8,
13,
49,
127,
205 
 758   Memantine hydrochloride   Memantine   D04905, D08174   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [3]
2,
6,
127 
 759   Mesencephalic neuronal precursor cells   -   -   -   -   [1]
6 
 760   Mesenchymal stem cells   -   -   -   -   [11]
2,
6,
13,
20,
49,
51,
60,
96,
222,
274,
299 
 761   Mestinon   Pyridostigmine   D00487   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [3]
3,
6,
11 
 762   Metformin   Metformin   D00944, D04966   [2] PRKAA1, PRKAA2   [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   [16]
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 763   Methylphenidate   Methylphenidate   D01296, D04999   [2] SLC6A2, SLC6A3   [6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   [7]
6,
13,
34,
84,
113,
179,
206 
 764   Methylphenidate (mpd)   Methylphenidate   D01296, D04999   [2] SLC6A2, SLC6A3   [6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   [1]
6 
 765   Methylphenidate hydrochloride   Methylphenidate   D01296, D04999   [2] SLC6A2, SLC6A3   [6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   [2]
6,
13 
 766   Mid dose anavex2-73   -   -   -   -   [1]
6 
 767   Midazolam   Midazolam   D00550, D00696, D05028   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [10]
2,
3,
6,
13,
46,
70,
96,
97,
231,
298 
 768   Midodrine   Midodrine   D01307, D08220   [3] ADRA1A, ADRA1B, ADRA1D   [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [3]
6,
17,
58 
 769   Minocycline   Minocycline   D00850, D05045   -   -   [13]
2,
6,
8,
13,
46,
85,
90,
94,
162,
201,
206,
280,
299 
 770   Minodronic acid   Minodronic acid   -   -   -   [4]
6,
46,
93,
95 
 771   Mirabegron   Mirabegron   D09535   [1] ADRB3   [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway   [3]
6,
13,
226 
 772   Mirapex   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 773   Mirapex (pramipexole)   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 774   Mirapex er   -   -   -   -   [1]
6 
 775   Mirapex la   -   -   -   -   [1]
6 
 776   Mirapexin   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 777   Mirapexin extended release various strengths   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 778   Mirapexin*30cpr 0,7mg   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 779   Mitoq   -   -   -   -   [1]
6 
 780   Mk0657   -   -   -   -   [1]
6 
 781   Moclobemide   Moclobemide   D02561   [1] MAOA   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 782   Modafinil   Modafinil   D01832   -   -   [4]
6,
13,
49,
93 
 783   Modafinil 50mg   Modafinil   D01832   -   -   [1]
6 
 784   Modiodal   -   -   -   -   [1]
6 
 785   Modopar   -   -   -   -   [1]
6 
 786   Monoamine oxidase b inhibitors   -   -   -   -   [1]
6 
 787   Motilium   -   -   -   -   [2]
6,
230 
 788   Moxifloxacin   Moxifloxacin   D00874, D08237   -   -   [8]
2,
6,
46,
49,
85,
86,
240,
299 
 789   Moxifloxacin infusion   Moxifloxacin   D00874, D08237   -   -   [1]
6 
 790   Moxifloxacina cloridrato   -   -   -   -   [1]
6 
 791   Muscimol   Muscimol   -   -   -   [1]
6 
 792   Mémantine   -   -   -   -   [1]
6 
 793   N-0923   -   -   -   -   [1]
6 
 794   N-acetylcysteine   Acetylcysteine   D00221   -   -   [10]
6,
13,
19,
20,
49,
58,
85,
111,
164,
299 
 795   N-acetylcysteine capsule   Acetylcysteine   D00221   -   -   [1]
6 
 796   N.a.   -   -   -   -   [8]
3,
6,
8,
13,
46,
97,
240,
256 
 797   N04bd02   -   -   -   -   [1]
6 
 798   Nabilone   Nabilone   D05099   [2] CNR1, CNR2   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [2]
6,
13 
 799   Nabilone 0.25 mg   Nabilone   D05099   [2] CNR1, CNR2   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [1]
6 
 800   Nacom   -   -   -   -   [1]
6 
 801   Nacom 100   -   -   -   -   [1]
6 
 802   Nacom levodopa+cardidopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 803   Nalmefene   Nalmefene   D05111   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 804   Naloxone   Naloxone   D01340, D08249   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [2]
6,
226 
 805   Naltrexone   Naltrexone   D02095, D05113   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [11]
6,
10,
13,
40,
41,
42,
43,
44,
45,
96,
97 
 806   Nardil   Phenelzine   D00505, D08349   [2] MAOA, MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 807   Nbtx-001   -   -   -   -   [1]
6 
 808   Nd0611   -   -   -   -   [1]
6 
 809   Nd0612   -   -   -   -   [1]
6 
 810   Nd0612 (levodopa/carbidopa solution)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 811   Nd1421   -   -   -   -   [1]
6 
 812   Nd1587   -   -   -   -   [1]
6 
 813   Nd1589   -   -   -   -   [1]
6 
 814   Nd1590   -   -   -   -   [1]
6 
 815   Nd1702   -   -   -   -   [1]
6 
 816   Nebicapone   Nebicapone   -   -   -   [1]
6 
 817   Nelotanserin   Nelotanserin   D09645   [1] HTR2A   [5] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse   [1]
6 
 818   Neridronic acid   Neridronic acid   -   -   -   [1]
6 
 819   Nerixia*im ev 1f 25mg   -   -   -   -   [1]
6 
 820   Neu-120   -   -   -   -   [1]
6 
 821   Neupro   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 822   Neupro 2 mg/24 h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 823   Neupro 2mg/24 h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 824   Neupro 2mg/24h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 825   Neupro 4 mg/24 h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 826   Neupro 4mg/24 h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 827   Neupro 4mg/24h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 828   Neupro 4mg/24hr transdermal patch   -   -   -   -   [1]
6 
 829   Neupro 6 mg/24 h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 830   Neupro 6mg/24 h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 831   Neupro 6mg/24h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 832   Neupro 8 mg/24 h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 833   Neupro 8mg/24h transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 834   Neupro*28cer 2mg/24h   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 835   Neupro*28cer 4mg/24h   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 836   Neupro*28cer 6mg/24h   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 837   Neupro*28cer 8mg/24h   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 838   Neupro*7cer 4mg/24h   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 839   Neupro*7cer 6mg/24h   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 840   Neupro*7cer 8mg/24h   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 841   Neupro®   -   -   -   -   [1]
6 
 842   Neuraceq   -   -   -   -   [1]
6 
 843   Neurobloc   -   -   -   -   [1]
6 
 844   Neuroepo   -   -   -   -   [1]
6 
 845   Neurohormonal mechanisms   -   -   -   -   [2]
6,
127 
 846   Neurpro   -   -   -   -   [1]
6 
 847   Niacin   Niacin   D00049   -   -   [3]
6,
78,
265 
 848   Niacinamide   Nicotinamide   D00036   -   -   [4]
5,
6,
13,
67 
 849   Nicorette 10mg/ 16 h   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 850   Nicorette 15 mg/ 16 h   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 851   Nicorette 5 mg/ 16 h   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 852   Nicotinamide   Nicotinamide   D00036   -   -   [3]
6,
49,
162 
 853   Nicotinamide riboside   Nicotinamide riboside   -   -   -   [1]
6 
 854   Nicotine   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [2]
6,
84 
 855   Nicotine gum   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 856   Nicotine nasal spray 10 mg/ml (0.5 mg/spray)   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 857   Nicotine patch   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [2]
6,
84 
 858   Nicotine transdermal patch   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 859   Nicotinell   -   -   -   -   [1]
6 
 860   Nicotinell 17,5 mg/24-stunden-pflaster   -   -   -   -   [1]
6 
 861   Nicotinell 35 mg/24-stunden-pflaster   -   -   -   -   [1]
6 
 862   Nilotinib   Nilotinib   D08953   [4] ABL1, KIT, PDGFRA, PDGFRB   [33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   [5]
6,
8,
34,
51,
86 
 863   Nilotinib 150mg oral capsule [tasigna]   Nilotinib   D08953   [4] ABL1, KIT, PDGFRA, PDGFRB   [33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   [1]
6 
 864   Nilotinib 300mg oral capsule [tasigna]   Nilotinib   D08953   [4] ABL1, KIT, PDGFRA, PDGFRB   [33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   [1]
6 
 865   Nitrogen   Nitrogen   D00083   -   -   [5]
5,
6,
17,
211,
299 
 866   Nly01   -   -   -   -   [1]
6 
 867   Nmda   Ketamine   D00711, D08098   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 868   Normal saline   -   -   -   -   [14]
6,
17,
22,
36,
46,
49,
60,
94,
96,
211,
226,
276,
296,
299 
 869   Northera   Droxidopa   D01277   [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 870   Nortriptyline   Nortriptyline   D00816, D08288   [2] SLC6A2, SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [2]
6,
226 
 871   Npc transplantation   -   -   -   -   [1]
6 
 872   Nr2b nmda antagonist cp-101,606 (traxoprodil)   Ketamine   D00711, D08098   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 873   Ns 2330   -   -   -   -   [1]
6 
 874   Ns2330   -   -   -   -   [1]
6 
 875   Nt 101   -   -   -   -   [4]
5,
6,
7,
17 
 876   Ntcell implantation   -   -   -   -   [1]
6 
 877   Null   -   -   -   -   [17]
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 878   Nw-1015   -   -   -   -   [1]
6 
 879   Nw-1015e, emd 1195686, msc2191632b   -   -   -   -   [1]
6 
 880   Nyx-458   -   -   -   -   [1]
6 
 881   Oc oral solution treatment a   -   -   -   -   [1]
6 
 882   Oc oral solution treatment b   -   -   -   -   [1]
6 
 883   Oc oral solution treatment c   -   -   -   -   [1]
6 
 884   Oc oral solution treatment d   -   -   -   -   [1]
6 
 885   Odm-101   -   -   -   -   [1]
6 
 886   Odm-101 105mg carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 887   Odm-101 65mg carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 888   Odm-104   -   -   -   -   [1]
6 
 889   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   [2] ATP4A, ATP4B   [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   [15]
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 890   Onabotulinumtoxin a injection   -   -   -   -   [1]
6 
 891   Onabotulinumtoxina   Botulinum toxin type a   D00783   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [3]
6,
13,
226 
 892   Ongentys   Opicapone   D10825   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 893   Ono-2160/cd   -   -   -   -   [1]
6 
 894   Ono-2370   -   -   -   -   [1]
6 
 895   Ono-2506po   -   -   -   -   [2]
2,
6 
 896   Opicapone   Opicapone   D10825   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 897   Opicapone (opc)   Opicapone   D10825   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 898   Optimal drug therapy   -   -   -   -   [1]
6 
 899   Optimized antiparkinsonian treatment   -   -   -   -   [1]
6 
 900   Oral escitalopram   Escitalopram   D02567, D07704, D07913   [1] SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [1]
6 
 901   Oral levodopa and carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 902   Oral levodopa/carbidopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 903   Orally disintegrating selegiline (zelapar)   Selegiline   D00785, D03731   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 904   Osu 6162 similar to (-)-osu 6162   -   -   -   -   [1]
6 
 905   Osu6162 similar to (-)-osu 6162   -   -   -   -   [2]
6,
8 
 906   Other nervous system drugs   -   -   -   -   [2]
6,
13 
 907   Other parkinson's disease treatments   -   -   -   -   [1]
6 
 908   Over-encapsulated entacapone tablets   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 909   Over-encapsulated modafinil   Modafinil   D01832   -   -   [1]
6 
 910   Oxaloacetate (oaa)   -   -   -   -   [1]
6 
 911   Oxb-102   -   -   -   -   [1]
6 
 912   Oxybate   Gamma-hydroxybutyric acid   -   -   -   [3]
6,
120,
149 
 913   Oxybuprocaine   Oxybuprocaine   D01768, D08319   [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   [1]
6 
 914   Oxybutynin   Oxybutynin   D00465, D00722   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 915   Oxybutynin and darifenacin   Darifenacin   D01699, D03654   [1] CHRM3   [9] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   [1]
6 
 916   Oxybutynin hydrochloride   Oxybutynin   D00465, D00722   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 917   Oxycodone   Oxycodone   D03783, D05312, D05462   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [7]
6,
13,
46,
70,
226,
231,
298 
 918   Oxycodone/naloxone prolonged release tablets   Oxycodone   D03783, D05312, D05462   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 919   P2b001   -   -   -   -   [1]
6 
 920   P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 921   P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 922   Paracetamol   Acetaminophen   D00217   [2] PTGS1, PTGS2   [21] Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   [5]
3,
6,
13,
35,
46 
 923   Parapres   -   -   -   -   [1]
6 
 924   Parcopa   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 925   Pardaprunox   -   -   -   -   [1]
6 
 926   Pardoprunox   Pardoprunox   D09397   [3] DRD2, DRD3, HTR1A   [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   [1]
6 
 927   Pardoprunox hydrochloride   Pardoprunox   D09397   [3] DRD2, DRD3, HTR1A   [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway   [1]
6 
 928   Paroxetine   Paroxetine   D02260, D02362, D05374, D05375   [1] SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [3]
6,
13,
46 
 929   Pbf-509   -   -   -   -   [1]
6 
 930   Pd patients h&y=1.5-2 medications off   -   -   -   -   [1]
6 
 931   Pd patients h&y=1.5-2 medications on   -   -   -   -   [1]
6 
 932   Pd patients h&y=3 medications off   -   -   -   -   [1]
6 
 933   Pd patients h&y=3 medications on   -   -   -   -   [1]
6 
 934   Pd vitamin supplementation   -   -   -   -   [1]
6 
 935   Perampanel   Perampanel   D08964   [4] GRIA1, GRIA2, GRIA3, GRIA4   [13] Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   [3]
2,
6,
144 
 936   Pergolide   Pergolide   D00502, D08339   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 937   Pf-06412562   -   -   -   -   [1]
6 
 938   Pf-06649751   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 939   Pf-06649751 high dose (15 mg qd)   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 940   Pf-06649751 low dose (1 mg qd)   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 941   Pf-06649751 middle dose 1 (3 mg qd)   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 942   Pf-06649751 middle dose 2 (7 mg qd)   Tavapadon   D11431   [2] DRD1, DRD5   [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway   [1]
6 
 943   Pf-06669571   -   -   -   -   [1]
6 
 944   Pharmacological treatment   -   -   -   -   [1]
6 
 945   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   [10]
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 946   Piclozotan   Piclozotan   -   -   -   [1]
6 
 947   Pilocarpine   Pilocarpine   D00525, D02200, D05478   [2] CHRM2, CHRM3   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [3]
6,
53,
299 
 948   Pimavanserin   Pimavanserin   -   -   -   [1]
6 
 949   Pimavanserin (acp-103)   Pimavanserin   -   -   -   [1]
6 
 950   Pimavanserin tartrate   Pimavanserin   -   -   -   [1]
6 
 951   Pimavanserin tartrate (acp-103)   Pimavanserin   -   -   -   [1]
6 
 952   Pioglitazone   Pioglitazone   D00945, D08378   [1] PPARG   [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   [17]
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 953   Piribedil   Piribedil   D07305   [2] DRD2, DRD3   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 954   Piribedil (clarium)   Piribedil   D07305   [2] DRD2, DRD3   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 955   Pitolisant   Pitolisant   D10749   [1] HRH3   [1] Neuroactive ligand-receptor interaction   [1]
6 
 956   Pittsburgh compound b   Pittsburgh compound b   -   -   -   [2]
6,
127 
 957   Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj   Amantadine   D00777, D07441   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [1]
6 
 958   Placebo   -   -   -   -   [20]
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 959   Plantago ovata husk   -   -   -   -   [1]
6 
 960   Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin)   Activated charcoal   D03251   -   -   [1]
6 
 961   Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin)   -   -   -   -   [1]
6 
 962   Pr oxycodone   Oxycodone   D03783, D05312, D05462   [3] OPRD1, OPRK1, OPRM1   [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 963   Pr001a   -   -   -   -   [1]
6 
 964   Pramipexol   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 965   Pramipexol extended release   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 966   Pramipexol immediate release   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 967   Pramipexole   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
2,
6 
 968   Pramipexole 0.125 mg tablets   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 969   Pramipexole 0.5 mg tablets   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 970   Pramipexole dihydrochloride   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 971   Pramipexole dihydrochloride extended-release tablets   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 972   Pramipexole dihydrochloride monohydrate   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 973   Pramipexole dihydrochloride monohydrate extended release   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 974   Pramipexole er   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 975   Pramipexole extended release   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 976   Pramipexole extended release tablet   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 977   Pramipexole immediate release   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 978   Pramipexole immediate release tablet   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 979   Pramipexole ir   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 980   Pramipexole or ropinirole   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 981   Pramipexole sr   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 982   Preladenant   Preladenant   D09717   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 983   Preladenant 10 mg tablet   Preladenant   D09717   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 984   Preladenant 2 mg tablet   Preladenant   D09717   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 985   Preladenant 5 mg tablet   Preladenant   D09717   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 986   Premarin ®   -   -   -   -   [1]
6 
 987   Pridopidine   Pridopidine   D09953   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
8 
 988   Prim-dj2727   -   -   -   -   [1]
6 
 989   Primary cervical dystonia (trihexyphenidyl)   Trihexyphenidyl   D00787, D08638   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [1]
6 
 990   Probiotic   -   -   -   -   [5]
2,
6,
96,
193,
266 
 991   Probiotic capsule   -   -   -   -   [1]
6 
 992   Prolonged release tablet   -   -   -   -   [1]
6 
 993   Prolopa®   -   -   -   -   [1]
6 
 994   Propofol   Propofol   D00549   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [8]
6,
21,
22,
34,
46,
84,
98,
296 
 995   Propofol-lipuro   Propofol   D00549   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
6 
 996   Propranolol   Propranolol   D00483, D08443   [3] ADRB1, ADRB2, ADRB3   [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway   [5]
6,
158,
167,
227,
278 
 997   Propranolol hcl cf 40 mg tablet   Propranolol   D00483, D08443   [3] ADRB1, ADRB2, ADRB3   [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 998   Prosavin   -   -   -   -   [1]
6 
 999   Proscar*30cpr riv 5mg   Finasteride   D00321   [1] SRD5A2   [2] Prostate cancer, Steroid hormone biosynthesis   [1]
6 
 1000   Prx002   -   -   -   -   [1]
6 
 1001   Pxt002331   -   -   -   -   [1]
6 
 1002   Pxt002331 - 20mg   -   -   -   -   [1]
6 
 1003   Pxt002331 - dose 1   -   -   -   -   [1]
6 
 1004   Pxt002331 - dose 2   -   -   -   -   [1]
6 
 1005   Pym50028   -   -   -   -   [1]
6 
 1006   Pyridostigmine   Pyridostigmine   D00487   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [4]
3,
6,
11,
256 
 1007   Pyridostigmine bromide   Pyridostigmine   D00487   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [3]
3,
6,
256 
 1008   Quetiapine   Quetiapine   D00458, D08456   [2] DRD2, HTR2A   [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   [2]
6,
13 
 1009   R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride   Benzofuran   -   -   -   [1]
6 
 1010   R-methugdnf   Liatermin   D04727   -   -   [1]
6 
 1011   Raav-gad   -   -   -   -   [1]
6 
 1012   Raclopride   Raclopride   -   -   -   [4]
5,
6,
7,
17 
 1013   Ramelteon   Ramelteon   D02689   [2] MTNR1A, MTNR1B   [2] Circadian entrainment, Neuroactive ligand-receptor interaction   [3]
6,
8,
46 
 1014   Rasagilin   -   -   -   -   [2]
5,
6 
 1015   Rasagilina   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1016   Rasagilina mesilato (12 weeks)   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1017   Rasagiline   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [4]
2,
5,
6,
17 
 1018   Rasagiline 1 mg capsule   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1019   Rasagiline 1mg tablet   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1020   Rasagiline 2 mg tablet   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1021   Rasagiline mesilate   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [3]
2,
5,
6 
 1022   Rasagiline mesylate   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [2]
6,
17 
 1023   Rasagiline mesylate 1.0 mg   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1024   Rasagiline mesylate plus mirapex   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1025   Rasagiline mesylate with levodopa   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1026   Rasagiline mesylate with requip   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1027   Rasagiline tablets   Rasagiline   D02562, D08469, D10829   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1028   Recombinant human cerebral dopamine neurotrophic factor   Dopamine   D00633, D07870   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1029   Recombinant-methionyl human glial cell line-derived neurotrophic factor   -   -   -   -   [1]
6 
 1030   Reduced glutathione   Glutathione   D00014, D00031   -   -   [2]
6,
299 
 1031   Reduced glutathione 100mg   Glutathione   D00014, D00031   -   -   [1]
6 
 1032   Reduced glutathione 200mg   Glutathione   D00014, D00031   -   -   [1]
6 
 1033   Remifentanil   Remifentanil   D01177, D08473   [1] OPRM1   [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   [2]
6,
70 
 1034   Remifentanyl   Remifentanil   D01177, D08473   [1] OPRM1   [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   [1]
6 
 1035   Reminyl retard   -   -   -   -   [1]
6 
 1036   Repaglinide   Repaglinide   D00594   [2] ABCC8, KCNJ11   [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus   [2]
6,
299 
 1037   Requip   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
309 
 1038   Requip pr   -   -   -   -   [1]
6 
 1039   Requip prolonged release   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1040   Requip xl prolonged-release   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1041   Requip*21cpr 5mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1042   Requip*28cpr 8mg r.p.   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1043   Requip-lp   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1044   Requip-modutab   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1045   Requip-modutab , 2mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1046   Requip-modutab , 4mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1047   Requip-modutab , 8mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1048   Requip-modutab, 2mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1049   Requip-modutab, 4mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1050   Requip-modutab, 8mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1051   Resistant maltodextrin   Maltodextrin   D02329   -   -   [1]
6 
 1052   Resistant starch   -   -   -   -   [1]
6 
 1053   Rifampicin   Rifampicin   D00211   -   -   [4]
6,
17,
46,
299 
 1054   Rifampin   Rifampicin   D00211   -   -   [5]
6,
13,
84,
86,
299 
 1055   Rifampin 300mg bid + istradefylline 40mg day 8 only   Istradefylline   D04641   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 1056   Rifaximin   Rifaximin   D02554   -   -   [5]
6,
96,
97,
99,
296 
 1057   Rifaximin 550 mg   Rifaximin   D02554   -   -   [1]
6 
 1058   Ritalin   Methylphenidate   D01296, D04999   [2] SLC6A2, SLC6A3   [6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   [2]
6,
13 
 1059   Rivastigmine   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [3]
5,
6,
13 
 1060   Rivastigmine capsule   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [1]
6 
 1061   Rivastigmine patch 9.5 cm2   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [1]
6 
 1062   Rivastigmine transdermal patch   Rivastigmine   D02558, D03822   [1] ACHE   [2] Cholinergic synapse, Glycerophospholipid metabolism   [2]
6,
13 
 1063   Rm-131   -   -   -   -   [1]
6 
 1064   Ro7046015   -   -   -   -   [1]
6 
 1065   Rop+l-dopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1066   Ropinirole   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [3]
6,
74,
309 
 1067   Ropinirole (as hydrochloride)   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1068   Ropinirole controlled-release (requip cr) for rls   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1069   Ropinirole cr 2mg tablet   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1070   Ropinirole cr 8mg tablet   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1071   Ropinirole hydrochloride   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [2]
6,
309 
 1072   Ropinirole hydrochloride extended-release tablet   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1073   Ropinirole hydrochloride extended-release tablet placebo   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1074   Ropinirole hydrochloride prolonged release   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1075   Ropinirole immediate release   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1076   Ropinirole implant   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1077   Ropinirole ir   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1078   Ropinirole ir tablets   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1079   Ropinirole monotherapy   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1080   Ropinirole oral product   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1081   Ropinirole pr   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1082   Ropinirole pr, 2mg   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1083   Ropinirole pr/xr   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1084   Ropinirole pr/xr tablets   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1085   Ropinirole prolonged release   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1086   Ropinirole prolonged release/extended release(pr/xr)   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1087   Ropinirole xl   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1088   Ropinirole xl (formerly cr)   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1089   Ropinirole/l-dopa   Ropinirole   D00784, D08489   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1090   Rosuvastatin   Rosuvastatin   D01915, D08492   [1] HMGCR   [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   [8]
6,
46,
49,
51,
79,
96,
271,
299 
 1091   Rotigotin   -   -   -   -   [1]
6 
 1092   Rotigotina   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1093   Rotigotine   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1094   Rotigotine (reference product pr 2.1.1)   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1095   Rotigotine (test product pr 2.3.1)   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1096   Rotigotine hydrochloride   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1097   Rotigotine nasal spray   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1098   Rotigotine transdermal patch   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1099   Rotigotine transdermal patch 2mg/24h(10cm2)   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1100   Rotigotine transdermal patch 4mg/24h (20cm2)   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1101   Rotigotine transdermal patch 6mg/24h (30cm2)   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1102   Rotigotine transdermal patch 8mg/24h (40cm2)   Rotigotine   D05768   [1] DRD2   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1103   Rozerem   Ramelteon   D02689   [2] MTNR1A, MTNR1B   [2] Circadian entrainment, Neuroactive ligand-receptor interaction   [1]
6 
 1104   Rq-00000010   -   -   -   -   [1]
6 
 1105   Rvg 55618   -   -   -   -   [1]
6 
 1106   Rvt-101 35 mg   -   -   -   -   [1]
6 
 1107   Rytary 145 mg   -   -   -   -   [1]
6 
 1108   Rytary 195 mg   -   -   -   -   [1]
6 
 1109   S 90049   -   -   -   -   [1]
6 
 1110   S 90049 - f36   -   -   -   -   [1]
6 
 1111   S 90049 - f38   -   -   -   -   [1]
6 
 1112   S.c. apomorphine   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1113   Safety observation   -   -   -   -   [1]
6 
 1114   Safinamida   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1115   Safinamide   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [2]
6,
17 
 1116   Safinamide + levodopa   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1117   Safinamide metansolfonato (12 weeks)   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1118   Safinamide methanesulfonate   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [2]
6,
17 
 1119   Safinamide methanesulfonate 100mg   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1120   Safinamide methanesulfonate 150mg   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1121   Safinamide methansulfonate   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1122   Safinamide, mao-b inhibitor   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1123   Sage   Sage   -   -   -   [2]
6,
8 
 1124   Sage leaf   Sage   -   -   -   [1]
6 
 1125   Sage-217   Sage   -   -   -   [1]
6 
 1126   Saline   Sodium chloride   D02056   -   -   [10]
6,
13,
17,
53,
67,
78,
86,
97,
168,
299 
 1127   Saline intranasal delivery   -   -   -   -   [1]
6 
 1128   Sam-e   Ademetionine   D07128   -   -   [1]
6 
 1129   Same   Ademetionine   D07128   -   -   [15]
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 1130   Saracatinib   Saracatinib   D09664   [2] ABL1, SRC   [45] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection   [2]
6,
89 
 1131   Sarcosine   Sarcosine   -   -   -   [1]
6 
 1132   Sarcosine capsule   Sarcosine   -   -   -   [1]
6 
 1133   Sargramostim   Sargramostim   D05803   [1] CSF2RA   [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer   [6]
6,
28,
60,
62,
96,
229 
 1134   Sarizotan   Sarizotan   -   -   -   [2]
6,
156 
 1135   Sarizotan hc1   Sarizotan   -   -   -   [1]
6 
 1136   Sarizotan hcl   Sarizotan   -   -   -   [1]
6 
 1137   Sarizotan hydrochloride   Sarizotan   -   -   -   [2]
6,
156 
 1138   Sch 420814   -   -   -   -   [1]
6 
 1139   Sch 420814 10 mg   -   -   -   -   [1]
6 
 1140   Sch 420814 100 mg   -   -   -   -   [1]
6 
 1141   Sch 900800   -   -   -   -   [1]
6 
 1142   Selegiline   Selegiline   D00785, D03731   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1143   Selegiline hcl 5 pch   Selegiline   D00785, D03731   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1144   Semaglutide   Semaglutide   D10025   [1] GLP1R   [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
6 
 1145   Semi continuous intra-oral administration of ld/cd   -   -   -   -   [1]
6 
 1146   Sep-363856   -   -   -   -   [1]
6 
 1147   Ser-214   -   -   -   -   [1]
6 
 1148   Serine   Serine   D00016   -   -   [3]
2,
6,
86 
 1149   Seroquel   Quetiapine   D00458, D08456   [2] DRD2, HTR2A   [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   [1]
6 
 1150   Sertraline   Sertraline   D00825, D02360   [1] SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [2]
6,
206 
 1151   Sevoflurane   Sevoflurane   D00547   -   -   [5]
6,
21,
22,
98,
296 
 1152   Sifol   -   -   -   -   [1]
6 
 1153   Sifrol   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1154   Sifrol 0,088   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1155   Sifrol 0,18   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1156   Sifrol 0,35   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1157   Sifrol 0,7   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1158   Sifrol, 0,35 mg tablette   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1159   Sifrol, 0,70 mg tablette   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1160   Sifrol®   -   -   -   -   [1]
6 
 1161   Sildenafil   Sildenafil   D02229, D08514   [1] PDE5A   [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   [15]
6,
46,
50,
51,
85,
86,
113,
210,
211,
212,
225,
226,
278,
294,
299 
 1162   Silodosin   Silodosin   D01965   [1] ADRA1A   [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
6 
 1163   Simvastatin   Simvastatin   D00434   [1] HMGCR   [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   [19]
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 1164   Simvastatine   Simvastatin   D00434   [1] HMGCR   [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   [2]
6,
13 
 1165   Sinemet   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1166   Sinemet (comparator)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1167   Sinemet (levodopa/carbidopa)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1168   Sinemet 100 mg + 25 mg compresse   -   -   -   -   [1]
6 
 1169   Sinemet 125 mg   -   -   -   -   [1]
6 
 1170   Sinemet 200mg/50mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1171   Sinemet 25-100   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1172   Sinemet 25/100   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1173   Sinemet cr   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1174   Sinemet cr 25mg-100mg extended-release tablet   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1175   Sinemet ir   -   -   -   -   [1]
6 
 1176   Sinemet plus   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1177   Sinemet plus (levodopa/carbidopa)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1178   Sinemet*50cpr 100mg+25mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1179   Sinemet®   -   -   -   -   [1]
6 
 1180   Sinemet® 100/25   -   -   -   -   [1]
6 
 1181   Sinemet® 100/25 mg   -   -   -   -   [1]
6 
 1182   Sinemet® controlled release (carbidopa/levodopa)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1183   Sinemet® cr   -   -   -   -   [1]
6 
 1184   Sinemet® cr 100/25   -   -   -   -   [1]
6 
 1185   Sinemet® plus 25 mg/100 mg tablets   -   -   -   -   [1]
6 
 1186   Sinemet®-plus tablets   -   -   -   -   [1]
6 
 1187   Sirio*30cpr eff 25mg+100mg   -   -   -   -   [1]
6 
 1188   Sk&f101468   -   -   -   -   [1]
6 
 1189   Slv308   -   -   -   -   [1]
6 
 1190   Slv308 (mono) hydrochlori   -   -   -   -   [1]
6 
 1191   Slv308 (mono) hydrochloride   -   -   -   -   [1]
6 
 1192   Slv308 hydrochloride   -   -   -   -   [1]
6 
 1193   Smilagenin   Smilagenin   -   -   -   [1]
6 
 1194   Snd 919   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1195   Snd 919 cl2 y   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1196   Snd 919 cl2y   Pramipexole   D00559, D05575   [3] DRD2, DRD3, DRD4   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1197   Snn0031   -   -   -   -   [1]
6 
 1198   Sodium chloride   Sodium chloride   D02056   -   -   [13]
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 1199   Sodium oxybate   Sodium oxybate   D05866   -   -   [3]
6,
120,
149 
 1200   Solifenacin   Solifenacin   D01269, D08522   [1] CHRM3   [9] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   [1]
6 
 1201   Solifenacin succinate (vesicare)   Solifenacin   D01269, D08522   [1] CHRM3   [9] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction   [1]
6 
 1202   Solu-cortef   Hydrocortisone succinate   D01442   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [3]
6,
81,
83 
 1203   Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial'   Hydrocortisone succinate   D01442   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
6 
 1204   Soy protein   -   -   -   -   [2]
6,
96 
 1205   Spheramine (bay86-5280)   -   -   -   -   [1]
6 
 1206   Spm 962   -   -   -   -   [1]
6 
 1207   Spm962   -   -   -   -   [1]
6 
 1208   Sqjz herbal mixtures   -   -   -   -   [1]
6 
 1209   Sr57667b   -   -   -   -   [1]
6 
 1210   Stalevo   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1211   Stalevo (levodopa/ carbidopa/ entacapone)   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 1212   Stalevo (levodopa/carbidopa/entacapona)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1213   Stalevo 100   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1214   Stalevo 100 mg/ 25 mg/ 200 mg filmtabletten   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1215   Stalevo 100/25/200 mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1216   Stalevo 150   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1217   Stalevo 150/37.5/200 mg   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1218   Stalevo*100cpr 100/25/200mg   -   -   -   -   [1]
6 
 1219   Stalevo*100cpr 50/12,5/200mg   -   -   -   -   [1]
6 
 1220   Stalevo®   -   -   -   -   [1]
6 
 1221   Standard ld/cd   -   -   -   -   [1]
6 
 1222   Standard of care   -   -   -   -   [8]
6,
13,
14,
49,
51,
64,
79,
85 
 1223   Stilnoct   -   -   -   -   [1]
6 
 1224   Strattera   Atomoxetine   D02574, D07473   [1] SLC6A2   [1] Synaptic vesicle cycle   [1]
6 
 1225   Study drug   -   -   -   -   [2]
6,
13 
 1226   Subcutaneous apomorphine   Apomorphine   D02004, D07460   [2] DRD1, DRD2   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1227   Subcutaneous hydrocortisone 10mg   Hydrocortisone   D00088   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
6 
 1228   Subjects will undergo the 123-i ibvm imaging visit   -   -   -   -   [1]
6 
 1229   Sugar pill   -   -   -   -   [7]
6,
49,
67,
70,
86,
206,
226 
 1230   Sulfate   Sulfate ion   -   -   -   [22]
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 1231   Sumanirole   Sumanirole   -   -   -   [1]
6 
 1232   Supplementation   -   -   -   -   [1]
6 
 1233   Supressi. t-diet plus range   -   -   -   -   [1]
6 
 1234   Suvorexant   Suvorexant   D10082   [2] HCRTR1, HCRTR2   [1] Neuroactive ligand-receptor interaction   [3]
5,
6,
13 
 1235   Syn120   -   -   -   -   [1]
6 
 1236   Tadalafil   Tadalafil   D02008   [1] PDE5A   [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   [6]
6,
51,
75,
84,
86,
113 
 1237   Talampanel   Talampanel   D02696   [4] GRIA1, GRIA2, GRIA3, GRIA4   [13] Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Transcriptional misregulation in cancer, cAMP signaling pathway   [2]
2,
6 
 1238   Tasmar   Tolcapone   D00786   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [2]
6,
28 
 1239   Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)   Hydrogen   -   -   -   [1]
6 
 1240   Td-9855   -   -   -   -   [2]
6,
17 
 1241   Technetium (99mtc) exametazime   Exametazime   D01109   -   -   [1]
6 
 1242   Terazosin   Terazosin   D00610, D08569   [3] ADRA1A, ADRA1B, ADRA1D   [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
6 
 1243   Terazosin 5 mg   Terazosin   D00610, D08569   [3] ADRA1A, ADRA1B, ADRA1D   [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
6 
 1244   Tesofensine   Tesofensine   -   -   -   [2]
6,
193 
 1245   Thn02   -   -   -   -   [1]
6 
 1246   Thn102 dosage a   -   -   -   -   [1]
6 
 1247   Thn102 dosage b   -   -   -   -   [1]
6 
 1248   Thn102 dosage c   -   -   -   -   [1]
6 
 1249   Tigan®   -   -   -   -   [1]
6 
 1250   Tolcapon   Tolcapone   D00786   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 1251   Tolcapone   Tolcapone   D00786   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [3]
6,
28,
127 
 1252   Topiramate   Topiramate   D00537   [36] CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [48] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [5]
6,
140,
144,
156,
193 
 1253   Topiramate (drug)   Topiramate   D00537   [36] CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [48] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy (DCM), Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy (HCM), Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
6 
 1254   Tozadenant   Tozadenant   D10174   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 1255   Tozadenant (syn115) 120 mg bid   Tozadenant   D10174   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 1256   Tozadenant (syn115) 180 mg bid   Tozadenant   D10174   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 1257   Tozadenant (syn115) 240 mg bid   Tozadenant   D10174   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 1258   Tozadenant (syn115) 60 mg bid   Tozadenant   D10174   [1] ADORA2A   [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway   [1]
6 
 1259   Traditional chinese medicinal mixture (composed of roucongrong and adjuvant)   -   -   -   -   [1]
6 
 1260   Transdermal nicotine   Nicotine   D03365, D05156, D05157   [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   [5] Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 1261   Trigel   -   -   -   -   [1]
6 
 1262   Trihexyphenidyl   Trihexyphenidyl   D00787, D08638   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [2]
5,
6 
 1263   Trimethobenzamide   Trimethobenzamide   D02733, D08643   -   -   [1]
6 
 1264   Trimethobenzamide hydrochloride   Trimethobenzamide   D02733, D08643   -   -   [1]
6 
 1265   Trivastal   Piribedil   D07305   [2] DRD2, DRD3   [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1266   Tropicamide   Tropicamide   D00397   [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   [11] Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway   [2]
6,
19 
 1267   Tryptophan   L-tryptophan   D00020   -   -   [1]
6 
 1268   Tryptophan (trp) depletion   L-tryptophan   D00020   -   -   [1]
6 
 1269   Tvp-1012   -   -   -   -   [1]
6 
 1270   Tvp-1012 (1 mg/day) with levodopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1271   Tvp-1012 0.5mg   -   -   -   -   [1]
6 
 1272   Tvp-1012 1mg   -   -   -   -   [1]
6 
 1273   Tvp-1012 1mg with levodopa   Levodopa   D00059   [5] DRD1, DRD2, DRD3, DRD4, DRD5   [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   [1]
6 
 1274   Tyrosine   Tyrosine   D00022   -   -   [3]
6,
86,
111 
 1275   Ub-312   -   -   -   -   [1]
6 
 1276   Ubiquinol   Ubiquinol   -   -   -   [3]
6,
8,
17 
 1277   Urate   Uric acid   -   -   -   [1]
6 
 1278   Ursodeoxycholic acid   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [8]
6,
67,
84,
93,
94,
95,
96,
97 
 1279   V1512   -   -   -   -   [1]
6 
 1280   V1512 and entacapone   Entacapone   D00781   [1] COMT   [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   [1]
6 
 1281   V81444   -   -   -   -   [1]
6 
 1282   Valerian   Valerian   -   -   -   [1]
6 
 1283   Varenicline   Varenicline   D08669   [2] CHRNA4, CHRNB2   [3] Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [2]
6,
18 
 1284   Varenicline tartrate   Varenicline   D08669   [2] CHRNA4, CHRNB2   [3] Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   [1]
6 
 1285   Variation of behaviors of parkinson's disease   -   -   -   -   [1]
6 
 1286   Vehicle   -   -   -   -   [4]
6,
36,
160,
192 
 1287   Venlafaxine   Venlafaxine   D00821, D08670   [2] SLC6A2, SLC6A4   [2] Serotonergic synapse, Synaptic vesicle cycle   [3]
6,
13,
46 
 1288   Vineuro   -   -   -   -   [1]
6 
 1289   Vitamin b12   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   [4]
6,
201,
229,
299 
 1290   Vitamin b12 supplementation   Cyanocobalamin   D00166, D03615, D03616, D03617   -   -   [1]
6 
 1291   Vitamin b6   Pyridoxine   D02179, D08454   -   -   [1]
6 
 1292   Vitamin d3   Cholecalciferol   D00188   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [11]
6,
13,
20,
46,
49,
53,
60,
65,
96,
97,
299 
 1293   Vitamin d3 - high dose   Cholecalciferol   D00188   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [1]
6 
 1294   Vitamin e   Vitamin e   D02331   -   -   [11]
2,
6,
13,
20,
46,
90,
96,
97,
206,
299,
317 
 1295   Viusid/alzer   -   -   -   -   [1]
6 
 1296   Vr040   -   -   -   -   [1]
6 
 1297   Vr040/aspirair® inhaler   -   -   -   -   [1]
6 
 1298   Vy-aadc01   -   -   -   -   [1]
6 
 1299   Vy-aadc02   -   -   -   -   [1]
6 
 1300   Warfarin   Warfarin   D00564, D01280, D08682   [2] NQO1, VKORC1   [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   [10]
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 1301   Water   Water   D00001   -   -   [18]
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 1302   Whey protein   -   -   -   -   [2]
6,
96 
 1303   White chocolate (0% cocoa)   Cocoa   -   -   -   [1]
6 
 1304   Wuling powder   -   -   -   -   [1]
6 
 1305   Xadago   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1306   Xadago (safinamide)   Safinamide   D10158   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1307   Xc130-a10h   -   -   -   -   [1]
6 
 1308   Xeomin   Botulinum toxin type a   D00783   [1] SNAP25   [2] Insulin secretion, Synaptic vesicle cycle   [7]
5,
6,
7,
13,
15,
17,
113 
 1309   Xiaoyao pill   -   -   -   -   [1]
6 
 1310   Xp21279   -   -   -   -   [1]
6 
 1311   Xp21279 and carbidopa (experimental)   Carbidopa   D00558   [1] DDC   [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1312   Zelapar   Selegiline   D00785, D03731   [1] MAOB   [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   [1]
6 
 1313   Zoledronic acid   Zoledronic acid   D01968, D06378, D06379, D08689   [1] FDPS   [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   [9]
6,
13,
46,
93,
95,
96,
274,
299,
333 
 1314   Zoledronic acid 5mg/bag 100ml inj   Zoledronic acid   D01968, D06378, D06379, D08689   [1] FDPS   [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   [1]
6 
 1315   Zolmitriptan   Zolmitriptan   D00415   [2] HTR1B, HTR1D   [4] Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway   [1]
6 
 1316   Zolpidem   Zolpidem   D00706, D08690   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [2]
5,
6 
 1317   Zolpidem first dose   Zolpidem   D00706, D08690   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
6 
 1318   Zolpidem second dose   Zolpidem   D00706, D08690   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
6 
 1319   Zolpidem tartrate   Zolpidem   D00706, D08690   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
6 
 1320   Zonegran   Zonisamide   D00538   [8] CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [11] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus   [1]
6 
 1321   Zonisamide   Zonisamide   D00538   [8] CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   [11] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus   [1]
6 
 1322   Zopiclone   Zopiclone   D01372   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [1]
6 

Back to top